title: Liraglutide for weight management: benefits and risks.
authors.affiliation: a Research Center for Translational Medicine, Shanghai East Hospital Affiliated to Tongji University School of Medicine , Shanghai , China.|b Department of Medicine & Therapeutics , The Chinese University of Hong Kong , Shatin , Hong Kong.
authors.forename: Brian
authors.initials: B
authors.lastname: Tomlinson
authors.affiliation: b Department of Medicine & Therapeutics , The Chinese University of Hong Kong , Shatin , Hong Kong.
authors.forename: Miao
authors.initials: M
authors.lastname: Hu
authors.affiliation: a Research Center for Translational Medicine, Shanghai East Hospital Affiliated to Tongji University School of Medicine , Shanghai , China.
authors.forename: Yuzhen
authors.initials: Y
authors.lastname: Zhang
authors.affiliation: c Division of Cardiology, Department of Internal Medicine , Wan Fang Hospital, Taipei Medical University , Taipei City , Taiwan.
authors.forename: Paul
authors.initials: P
authors.lastname: Chan
authors.affiliation: d Department of Cardiac Surgery , Shanghai East Hospital, Tongji University , Shanghai , China.
authors.forename: Zhong-Min
authors.initials: ZM
authors.lastname: Liu
mesh_terms: D001835:Body Weight; D003924:Diabetes Mellitus, Type 2; D052216:Glucagon-Like Peptide 1; D007004:Hypoglycemic Agents; D000069450:Liraglutide; D009765:Obesity; D018570:Risk Assessment; D015431:Weight Loss
chemical_list: D007004:Hypoglycemic Agents; D000069450:Liraglutide; D052216:Glucagon-Like Peptide 1